suMMARY Noradrenaline uptake was studied using heart muscle from 102 patients undergoing cardiac surgery. Slices of right atrium were incubated in Krebs-Henseleit solution containing 1-3 x 10-M 3H-noradrenaline. Uptake was lower in failing heart muscle and was inhibited not only by increasing the noradrenaline concentration in the incubating medium but also by adding the drugs desmethylimipramine, amitryptyline, and ouabain.
The adrenergic neurone possesses an efficient uptake mechanism whose properties are well known. Noradrenaline is the preferred substrate but the process exhibits stereochemical and structural specificity so that adrenaline and dopamine are also substrates whereas isoprenaline is not. Uptake is energyandtemperature dependent; it obeys enzyme kinetics and is inhibitedbya rangeof drugs including cocaine, the tricyclic antidepressants, and the cardiac glycosides (Iversen, 1967 (Iversen, , 1973 von Euler, 1972) . Neuronal uptake of adrenaline and noradrenaline removes these catecholamines from the extracellular space and thus terminates their effects. This paper describes, for the first time, the neuronal uptake of catecholamines by human cardiac muscle. The experiments were performed in vitro. (Iversen, 1963 DL-(7-3H) noradrenaline hydrochloride (specific activity 15 Ci/mmol, DL-(7-3H)), isoprenaline (specific activity 10 Ci/mmol and DL-(7-3H)), adrenaline (specific activity 14-3 Ci/mmol) were supplied by the Radiochemical Centre, Amersham, U.K. The following drugs were kindly donated by the pharmaceutical industry-desipramine HC1 (Geigy), lignocaine HC1 (Astra), amitriptyline HC1 (Merck, Sharp and Dohme), dl propranolol HC1 (Imperial Chemical Industries Ltd.); ouabain was supplied by British Drug Houses. 20-42 + 6 15 n = 7 n = 9
Results
After 10 minutes incubation in Krebs-Henseleit solution containing 1-3 x 10-7 M 3H-noradrenaline the concentration ratio for a 'control' group of 6 patients was 9-28 ± 2-84. These patients were undergoing coronary artery bypass operations, and had normal cardiac function at rest; none had ever received treatment with digoxin or diuretics. In 8 patients with cardiac failure undergoing aortic or mitral valve replacement the corresponding concentration ratio was 5 46 ± 1 53 (Fig. 1) .
When the experiments were repeated using 3H-sorbitol, no significant difference between the two groups was detected; the mean concentration ratio for the two groups combined was 0 36 ± 0 01 (n = 9). There was no difference between the samples from patients undergoing aortic, as compared with mitral valve replacement though the incubation time was extended to one hour (Table 1) . Slices of left ventricular muscle accumulated 13 x 10-7 M 3H-noradrenaline more slowly than right atrial muscle so that after one hour of incubation the concentration ratio was 8 86 ± 3 12. This was significantly lower than the concentration ratio obtained for right atrial samples taken from patients with cardiac failure, which was 20 65 ± 615 (Fig. 2) .
The effect of noradrenaline concentration on the initial uptake velocity was examined using right atrial samples from patients with cardiac failure and a 5-minute incubation time; the concentration ratio fell as the noradrenaline concentration in the incubating medium increased (Table 2) Adrenaline was taken up by slices of right atrial muscle from patients with cardiac failure though the concentration ratios were lower than those for noradrenaline. After 10 minutes of incubation with 1-3 x 10-7 M adrenaline the ratio was 3 30 + 0-56 (n = 7); after 10 minutes of incubation in the presence of 10-6 M desipramine the concentration ratio was 1-58 ± 0-24. 10-5 M isoprenaline was not was possible to calculate the initial uptake velocity, the resuJts obtained using 3H-noradrenaline concentrations over 3 ,uM were less accurate as the concentration ratios approached the blank value (Fig. 3) . Nevertheless, the uptake velocity did not increase linearly as the noradrenaline concentration was increased and a reciprocal plot of the 0 3, 0 9, and 3 0 ,uM values approximates to a straight line; the Michaelis constant and maximum uptake velocity were 1-5 HtM and 0 7 nmol/min per g, respectively (Fig. 4) . The uptake of 1-3 x 10-7 3H-noradrenaline by slices of right atrial muscle was inhibited by the tricyclic antidepressants desipramine and amitriptyline (Table 3) ; lignocaine and propranolol were without effect. Ouabain inhibited noradrenaline uptake in a group of 4 patients undergoing coronary artery bypass surgery, none of whom had ever received treatment with digitalis glycosides (Table 4 ). The same effect could be detected in Table 4 Effect of ouabain on noradrenaline uptake 
Discussion
Noradrenaline uptake was demonstrable at low external amine concentrations, was temperature sensitive, and was inhibited byincreasingthe external amine concentration and by desipramine, amitriptyline, and ouabain; adrenaline was taken up whereas isoprenaline was not. These are the features of the neuronal uptake process and it, therefore, appears that noradrenaline was being taken up by the sympathetic neurones of the right atrial samples. This study is the first demonstration of the neuronal uptake process in human cardiac muscle. It is likely that the techniques we have used would underestimate the velocity of the uptake process which may be more rapid in vivo (Petch, 1977) . The depressant effect of cardiac failure on the neuronal uptake process has been shown in the heart muscle of experimental animals (Fischer et al., 1965; Spann et al., 1965; Sassa, 1971) ; it is also suggested by the results obtained in the present study. However, all patients with cardiac failure had received treatment with digitalis glycosides whose inhibitory effect on 3H-noradrenaline uptake was confirmed in a separate experiment. Thus, it is possible that both the presence of cardiac failure and treatment with cardiac glycosides contributed to the depression of noradrenaline uptake observed in the samples of right atrial muscle taken from patients undergoing valve replacement and the relative importance of the two factors cannot be determined.
Regional differences in the activity of the neuronal uptake process, like the differences in catecholamine concentration, reflect the density of sympathetic innervation (Iversen, 1967) . The greater uptake of 3H-noradrenaline by human right atrial muscle slices compared with left ventricular muscle was thus in keeping with our earlier observation of a higher noradrenaline concentration in the former (Petch and Nayler, 1979) .
The clinical importance of the neuronal uptake process is that it determines the concentration of catecholamines at the cardiac adrenoceptor. Thus those factors that impair neuronal uptake such as an autonomic neuropathy, cardiac failure, and ischaemia, and the presence of digitalis glycosides or tricyclic antidepressants, will potentiate the cardiac effects of adrenaline and noradrenaline. 
